International Clinical Trial: Protocol of a Single-Center, Bidirectional Cohort Study Comparing "Dual Conversion" with LVD Combined with TACE versus "Single Conversion" with TACE Alone for Initially Unresectable Hepatocellular Carcinoma

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119975) titled 'Protocol of a Single-Center, Bidirectional Cohort Study Comparing "Dual Conversion" with LVD Combined with TACE versus "Single Conversion" with TACE Alone for Initially Unresectable Hepatocellular Carcinoma' on March 6.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: West China Hospital, Sichuan University

Condition: Unresectable hepatocellular carcinoma (HCC)

Intervention: Experimental group:TACE-LVD "dual conversion" therapy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-31

Target Sample Size: Experimental group:56;Control gr...